BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs6983267
,
DRD2
,
nitric oxide metabolic process
,
Ischemia
,
Heart
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
topoisomerase I inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Antitumor agents 294. Novel E-ring-modified camptothecin-4β-anilino-4'-O-demethyl-epipodophyllotoxin…
SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-…
3-Arylisoquinolines as novel topoisomerase I inhibitors.
Topoisomerase I inhibitors in the treatment of primary CNS malignancies: an update on recent trends.
Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibit…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Study of Intrathecal Topotecan
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmon…
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
PRE-I-SPY Phase I/Ib Oncology Platform Program
Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ